I mentioned before they should focus on LH (here o
Post# of 148292
The cans been kicked too long on m/m, s/c...
The FDA never recognized what LL could do for m/m. They will not recognize s/c until several of the other drugs get approval/eua. S/C is getting crowded and it appears the SOC is going to make it more difficult for us to get recognition and stand apart from all the other drugs.
No one else that I am aware is focusing on LH. We should become the SOC!
Even with only phase 2 results. We are the only game in town. Long haulers are there waiting for care. The endpoints are simple... How did you feel the last three months (arbitrary timeline)??? How do you feel now??? The physicians treating the long hauler patients should be intimately familiar with their symptoms, and it will be overwhelmingly obvious if LL is working.
Fck the FDA. If we are going to win we have to be the only team playing the game. LH gives us this opportunity.
Once approved doctors can use us for S/C and M/M
All focus should be turned to LH. I hope the recent hire at COO indicates this is what we are doing.